about
Clinical, Biochemical and Molecular Characteristics of the Main Types of PorphyriaPrediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients.Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.Nine novel mutations in the hydroxymethylbilane synthase gene of Polish patients with acute intermittent porphyriaHLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donorRole of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantationKIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules
P50
Q28072248-C182D0A0-3622-4E0C-A148-BCE832C4EC8BQ39117286-5854A344-ED16-447F-8453-76C3332B2FB6Q41532474-C6651216-D846-4E7A-BF67-EF92E4C16F57Q48846219-BB2E8D36-9C14-4BBE-8B2C-402B5F1C905CQ53525337-D0EA6F48-3827-4935-91AA-F9F6B8639D22Q82853830-86159F4D-2119-49CA-B258-74E1ECD905D5Q88236777-5E5E0A72-D0D0-4EAE-B692-2DFAC68BBE5BQ91245472-8ECA2D5A-1128-40BC-9B72-8C7CBC162DFDQ92835861-0119D049-ED60-4D35-95F9-C406F1AFF143
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Urszula Szlendak
@en
Urszula Szlendak
@nl
type
label
Urszula Szlendak
@en
Urszula Szlendak
@nl
altLabel
Szlendak U
@en
prefLabel
Urszula Szlendak
@en
Urszula Szlendak
@nl
P31
P496
0000-0001-5540-8060